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INTRODUCTION 
Anaemia is a major public health problem especially among the poorer 
segments of the population in developing countries like India and it is one of 
the major challenges an obstetrician faces in his / her carrier. 
In India, it is frequently severe and contributes to maternal mortality and 
reproductive health morbidity.  It deserves more attention than its currently 
receiving. Recently lot of programmes have been focussed on safe motherhood 
but maternal anaemia remains a problem of great concern. 
Gender discrimination is another important factor in India as the girl 
child, right from youth, is denied proper food and education. 
Anaemia in pregnancy accounts for 25 percent of deaths due to 
associated causes and 11.5% of all maternal deaths (Mudaliar). Anaemia 
contributes to 10-15% of direct maternal deaths in India. (Mudaliar) 
An estimated 60% of all pregnant women in developing countries have 
anaemia.  Anaemia either directly or indirectly contributes to about 20% of 
maternal deaths in third world countries. 
Among all causes of anaemia, nutritional anaemia is of greatest concern, 
90% due to iron deficiency (Fenton 1997). 
In places where malaria or hook worm infestation is endemic, 
prevalence of anaemia is as high as 90% (Agarwal AK et al 1999). Konnon 
(1994) studied the incidence of anaemia in adolescent girls in slum areas in the 
city of Baroda,  98% of adolescent girls were anaemic. This adversely affects 
reproductive performance. 
Multipara, multiple pregnancy, blood donors and persons with a diet low 
in meat / vegetarian (Chegget et al 1996) are more prone for anaemia. 
Adolescents because of their low body iron stores are also at risk. 
In India the prevalence of iron deficiency anaemia has come down due 
to fortification, prophylactic iron supplementation, better health care 
programmes aimed at women and children (School Hedige 1994). 
The incidence and prevalence of anaemia in the pregnant women of 
North Chennai is very high.  Most of the women attending the antenatal OPD 
have a Hb around 8-10gm/dl.  These patients come from a low socioeconomic 
strata. They are unable to come for regular antenatal checkups. They prefer to 
work and earn their livelihood rather than get admitted and get their anaemia 
treated.  This  dissertation attempts to analyse the maternal and fetal outcome 
of pregnancy in anaemic women and study the effect of birth spacing in 
improving the same. 
Prevention is better than cure. This study could guide us as to the levels 
at which we need to direct our preventive measures to check the progress of 
anaemia in antenatal women and improve our out reach services  thereby 
identifying anaemia in the adolescent stage.   
NEED FOR THE STUDY 
Prevention of anaemia is essential in normal care to have a healthy baby 
from a healthy mother and thereby build a healthy nation. 
Anaemia is the most important complication in pregnancy in developing 
countries not only because of its high incidence but also because of its severity.   
WHO UNICEF collaboration survey in developing countries and ICMR studies 
in Indian context revealed that out of the total women suffering from anaemia 
2/3 are pregnant and lactating mothers (Nailk D. Jayshree  & Malatikeshan – 
1992). 
Anaemia of pregnancy is mainly nutritional-iron, folate and B12 
deficiency; most commonly due to non-availability of correct food and food 
taboos and cooking customs. Studies reveal that socioeconomic, cultural factors 
influence dietary inadequacy during pregnancy which is attributed to poor 
purchasing power, illiteracy, ignorance regarding nutritive value of readily 
available cheaper foodstuffs, cultural taboos, superstition and large family 
(Menon Krishnan et al 1995,  Rull Benett and Brownlinding 1993,  Nailk / D 
Jayashree 1992). Factors like chronic illness, haemorrhage  short birth 
intervals, parity will also influence the prevalence of anaemia during pregnancy 
(Ratnan et al 1993). Severe forms of anaemia in III trimester of pregnancy are 
invariably associated with cardiac failure,  20%   deaths, low birth weight,  
prematurity, perinatal and infant mortality (Mennon Krishnan et al 1996). 
According to Hassan Masood 1991 anaemia is prevalent in 50-90% 
pregnant women in India which is No.1 Killer. 
Despite considerable improvement and awareness in Antenatal care in 
developing countries and inspite of MCH programmes and National Anaemia 
Prophylaxis in India,  anaemia remains a great concern with regard to maternal 
morbidity and mortality and adverse outcome (Singh Krishnan et al 1995). 
Anaemia may antedate conception, its often aggravated by pregnancy 
and the accidents of labour may perpetuate it.  It is one of the prime concerns of 
the antenatal care to forestall it, for the safety of labour and puerperal state.  
The incidence of anaemia has been on the rise for past several decades in 
different parts of the world, more so in developing countries.  Recent reports 
indicate the increase in maternal morbidity, mortality and adverse fetal 
outcome when anaemia complicates pregnancy.  To decrease this, obstetricians 
have been stressing on regular antenatal checkup. Thus an effort has been made 
to know the effects of anaemia on fetomaternal outcome in this study. 
AIM OF THE STUDY 
To study women presenting in the antenatal department with various 
degrees  of anaemia and find out its effect on 
¾ Maternal morbidity and mortality 
¾ Mother in puerperium 
¾ Fetal morbidity and mortality 
¾ Baby in the neonatal period 
HISTORICAL ASPECTS OF ANAEMIA 
The work of Hedin and Wintrobe in assessing the volume of packed red 
cells by various types of hematocrit and the work of Keith, Rewntree and 
Garathy in estimating blood volume led to the accurate laboratory definition of 
the presence or absence of anaemia. 
Pierre Blaud in 1832, discovered that ferrous sulphate tablets were 
effective therapy for iron deficiency anaemia. 
In 1919 Sir William Osler classified anaemia as occurring during 
pregnancy, following post partum haemorrhage, associated with post partum 
sepsis or other postpartum anaemia. 
In 1922 Price quantitated  the variation in red cell size seen in various 
types of anaemia. 
In 1932 Wintrobe devised the concept of red cell indices. 
REVIEW OF LITERATURE 
ANAEMIA IN PREGNANCY 
Anaemia is perhaps the most common complication in pregnancy met 
with in the tropics. 
Studies carried out in the forties and fifties had shown that in India. 
¾ In India the incidence of anaemia is 40% – 90%  
¾ Iron and folic acid deficiency were the major factors responsible for 
anaemia, due to nutritional deficiency (diet). 
¾ Anaemia in pregnancy accounts for 25% of deaths due to associated causes 
and 11.5% of all  maternal deaths.(Mudaliar) 
¾ Anaemia in pregnancy was associated with a high perinatal loss. 
Management of anaemia in pregnancy was therefore accorded a very 
high priority both in obstetric and public health practice. The National Anaemia 
Prophylaxis Programme was implemented in 1972 hoping to reduce its 
prevalence and severity in pregnancy.  But unfortunately studies carried out 
during the late eighties in India failed to show any change in either the 
magnitude or its adverse obstetric consequences. 
DEFINITION 
A clear definition of anaemia in women is complicated by normal 
variations of haemoglobin levels between men and women, between pregnant 
and non-pregnant, between the various socio-economic standards and between 
those who receive nutritious diet and iron supplements and those who do not. 
In anaemia there is a low haemoglobin concentration resulting in 
decreased oxygen carrying capacity of the blood. 
The WHO expert group had defined anaemia as a haemoglobin level 
less than 11g/dl. The Centers for Disease Control (1990) has defined anaemia 
as less than 11g/dl in the first and third trimesters and less than 10.5g/dl in the 
second trimester. 
In India anaemia is defined as Hb < 10gm /dl as given by Federation of 
Obstetrics and Gynaecological Society of India (Mudaliar). 
This difference in the cut-off value according to gestational age is based 
on the fact that the fall in haemoglobin level in pregnancy is most marked in 
the mid –trimester due to a relatively greater expansion of the plasma volume 
compared with the haemoglobin mass and red cell volume.  Late in pregnancy, 
plasma expansion essentially ceases while haemoglobin mass continues to 
increase. 
Degrees of Anaemia  
Asian Journal of OG - 1999 
Mild Anaemia  9.1-11gm/dL 
Moderate   7.1 – 9gm/dL 
Severe  Hb < 7gm/dL 
ETIOLOGY OF ANAEMIA IN PREGNANCY  
Physiological anaemia of pregnancy. 
Pathological 
• Deficiency anaemia (Isolated or combined) 
 Iron deficiency 
 Folic acid deficiency 
 Vitamin B12 deficiency 
 Protein deficiency 
• Haemorrhagic 
 Acute following bleeding in early months or APH 
 Chronic – Hookworm infestation, bleeding piles 
 
• Hereditary 
 Thalassemias 
 Sickle cell haemoglobinopathies 
 Other haemoglobinopathies 
 Hereditary hemolytic anaemias. 
 RBC membrane defects 
 Spherocytosis 
• Bone marrow insufficiency 
 Hypoplasia or aplasia due to irradiation 
 Drugs aspirin, indomethacin 
 Anaemia of infection (Malaria, tuberculosis) 
 Chronic renal disease or neoplasm. 
ETIOLOGY OF ANAEMIA IN PREGNANCY  
Changes in Hb levels during pregnancy: 
In pregnancy there is progressive increase in circulating blood volume 
due to increase in plasma and RBC volume. Increase in blood volume ranges 
from 30-70% of the non-pregnant level. The increase in plasma volume is 
greater (40 to 50%) than the rise in RBC volume  
(18-25%) so there is a fall in Hb levels.  The fall is physiological because : 
a) It begins in the first trimester when iron needs are fully met. 
b) It occurs in well nourished women also 
c) It is not eliminated by administration of iron. 
Repeated pregnancies at short intervals.  It takes 2 years to replenish 
1000mg of iron lost in pregnancy and lactation. 
Folate deficiency is seen among lower socioeconomic groups (as vegetable 
intake especially green leafy  vegetables, is very low, in mutipara and in 
malabsorption syndrome. 
IRON REQUIREMENT IN PREGNANCY  
In a typical singleton gestation, the maternal need for iron averages 
close to 800mg – 300mg for the fetus and placenta and 500mg, if available, for 
maternal haemoglobin mass expansion,  200mg are shed through gut, skin and 
urine. The total amount (1000mg) exceeds the iron stores of most women and 
results in  iron deficiency anaemia. 
Iron deficiency anaemia during pregnancy is the consequence primarily 
of expansion of plasma without normal expansion of maternal haemoglobin 
mass (Williams 22nd ed.) 
IRON ABSORPTION IN PREGNANCY 
Early in pregnancy iron absorption is decreased. It shows a marked 
improvement from about the twentieth week, reaching three times the control 
value by the thirty sixth week of gestation. Despite this, the iron requirements 
of pregnancy cannot be adequately fulfilled even from a diet of over 2000 
kcal/day.  The deficit of iron, towards the last trimester may be as high as 4-
5mg / day. 
In health, the serum iron concentration of adult non-pregnant women 
lies between 13 and 27 μmol/l.  It shows marked individual diurnal variation 
and fluctuates even from hour to hour.  The total iron binding capacity 
(TIBC). In the non-pregnant state lies in the range  
45-72 μmol/L.  It is raised in association with iron deficiency and low in 
chronic inflammatory states.  In the nonanaemic person the TIBC is 
approximately one third saturated with iron. Serum iron even in combination 
with TIBC is not a reliable indicator of iron stores because it  fluctuates so 
widely, is affected by recent ingestion of iron and infection (De Swiet 4th edn). 
Serum Ferritin is stable, not affected by recent ingestion of iron, 
reflects the iron stores.  In iron deficiency, serum ferritin is the first to fall. 
Serum ferritin is estimated by sensitive immunoradiometric assay. Anaemic 
mothers have low serum cord ferritin. 
Serum Transferin Receptor (TfR)  
Is present in all cells as a transmembrane protein that binds transferrin 
iron and transports it to the cell interior. Serum TfR   is a reliable indicator of 
cellular iron status. TfR will give a true reflection of tissue iron deficiency in 
pregnancy when ferritin may be low because of mobilisation and in chronic 
inflammatory disease when ferritin is inappropriately elevated because of 
release from cells. 
Marrow Iron – No stainable iron (Haemosiderin) may be visible once 
serum ferritin has fallen to below 30μg/l (Deswict). 
RDW – Red Cell Distribution Width. It is an index of the presence of 
heterogenous RBC with different diameters.  If it is more than 15% it is 
abnormal.  It occurs even before the peripheral smear becomes microcytic 
hypochromic. 
FOLIC ACID DEFICIENCY  
It was called pernicious anaemia of pregnancy.  It is found in women 
who do not consume fresh green leafy vegetables, legumes or animal protein. 
Folic acid requirement is 400μg/day in the pregnant women (Williams’s) 
The earliest biochemical evidence is low plasma folic acid 
concentration. The earliest morphological evidence is hypersegmentation of 
neutrophils, and newly formed erythrocytes are macrocytic. 
Additional folic acid is given in 
1) Multifetal pregnancy 
2) Hemolytic anaemia 
3) Crohn’s disease 
4) Alcoholism 
5) Inflammatory skin disorders 
6) Previous baby had neural tube defects 
VITAMIN B12 DEFICIENCY 
In addisonian pernicious anaemia, a lack of intrinsic factor results in 
failure to absorb vitamin B12.  Infertility is a complication. 
Vit. B12, deficiency is more likely following  
1) Partial or total gastric resection 
2) Crohn’s disease 
3) Ileal resection 
4) Bacterial overgrowth in the small bowel. 
 
ANAEMIA DUE TO BLOOD LOSS 
Hookworm infestation is the most common cause in tropical countries  
1) Ankylostoma duodenale – 0.25 ml/worm /day 
2) Necator americanus 0.03 ml/worm/day 
ANAEMIA DUE TO HEMOLYSIS  
Falciparum malarial infections may cause hemolytic anaemia in  
addition to all the hemolytic anaemias of genetic origin. 
Anaemia associated with infections  
1) UTI 
2) HIV perse does not cause anaemia, though in rare instances anaemia as a 
part of pancytopenia due to HIV infection have been reported. 
Chronic renal disease results in decreased production of erythropoietin 
and hence anaemia. 
CLINICAL FEATURES 
They depend more on the degree of anaemia than anything else. 
In majority, the patients have got no symptoms and the entity is detected 
accidentally during examination. 
SYMPTOMS 
Lassitude, a feeling of exhaustion may be the earliest manifestation. 
Anorexia, indigestion 
Palpitation caused by ectopic beats 
Dyspnoea 
Giddiness 
Swelling of legs. 
ON EXAMINATION 
- Pallor of varying degrees 
- Glossitis, stomatitis 
- Oedema legs due to hypoproteinemia  or associated pre-eclampsia 
- Soft systolic murmur 
- Crepitations at the base of the lungs due to congestion. 
COMPLICATIONS OF SEVERE ANAEMIA 
During Pregnancy 
The following complications are likely to increase 
1) Pre-eclampsia 
2) Intercurrent infection 
3) Heart failure at 30-32 weeks of pregnancy 
4) Preterm labour 
During Labour 
1) Cardiac Failure : May be due to accelerated cardiac output which occurs 
during labour or immediately following delivery. 
2)   Shock 
3) Post partum haemorrhage 
4) Uterine inertia – it is not a common associate 
During Puerperium 
1) Puerperal sepsis 
2) Subinvolution 
3) Failing lactation 
4) Peripheral venous thrombosis 
5) Pulmonary embolism 
Risk Periods 
1) AT 30-32 wks of pregnancy 
2) During labour 
3) Immediately following delivery 
4) In puerperium 7-10 days following delivery due to pulmonary     
           embolism. 
Anaemia directly or indirectly contributes to about 20% of maternal 
deaths in the third world countries. 
Effects on the baby : 
Increased incidence of  
1) Low birth weight 
2) Preterm babies 
3) Intrauterine death – due to severe maternal anoxemia 
Net effect  
Increased perinatal loss 
Treatment 
This depends on the Hb level and the gestational age at which the patient 
presents. 
All patients with Hb< 7gm/dl must be admitted. 
Patients with Hb < 5gm/dl and especially those with  
Hb < 2.5gm/dl and PCV< 15% congestive failure is always present. 
Congestive failure is a contraindication for parenteral iron therapy. 
Nothing can be more dangerous than terminating pregnancy in  a patient 
with severe anaemia. 
Rest, sedation, digitalis and diuretics to control the failure and repeated 
packed cell transfusion to improve anaemia are useful in tiding over the crisis.  
For patients who are not in failure  
1) Parenteral iron therapy 
Patients who 
a. Require a quick response especially when she is near term 
b. Cannot tolerate iron by mouth 
c. Do not show satisfactory response to oral iron 
The Hb increases by 0.7 to 1gm/100 ml per week. 
A) Intravenous Route : 
TDI – Total Dose Infusion 
The deficit of iron is first calculated and the total amount of iron 
required to correct the deficit is administered by a single sitting IV infusion. 
Iron Dextran is used. 
Advantages : 
1) Eliminates repeated, painful IM injections 
2) Treatment is completed in a day 
3) It is less costly 
 
Limitations 
1) As the maximum response does not appear before 4-9 weeks, the method is 
unsuitable if 4 weeks are not available for delivery.  It is most suitable 
between 30-36 weeks of pregnancy. 
2) Previous history of reaction to parenteral therapy. 
3) IV iron can produce severe anaphylactoid reactions. 
TDI = (Hb deficit x weight in Kg x 2.21)  + 1000 in mg  
 
B) Intramuscular Route : 
Iron dextran (Imferon) 
Iron sorbitol citric acid complex 
  (Jectofer) 
Oral iron should be suspended 24 hours prior to parenteral therapy to 
avoid reactions. 
 
Drawbacks : 
1) Painful 
2) Abscess formation and discolouration of skin over the injection site 
especially with imferon. 
3) Pyrexia, lymphadenopathy, headache, nausea, vomiting and allergic 
reactions. 
C) Blood / Packed cell transfusion  
1) Correct anaemia due to APH or PPH 
2) Severe anaemia beyond 36 weeks 
3) Refractory anaemia 
4) Associated infection 
D) Oral Iron Therapy 
Ferrous gluconate,  ferrous fumarate or ferrous succinate. 
Fersolate – 200mg ferrous sulphate which contains 60mg of elemental iron. 
Adverse effects : 
Most common – constipation 
Epigastric pain, nausea, vomiting and diarrhoea are other effects. 
The reticulocyte count increases by 7-10 days. 
Hb. rises at the rate of 0.7gm/100ml per week. 
To replenish iron stores oral therapy should be continued for 3 months 
after anaemia is corrected. 
The National Anaemia Prophylaxis Programme distributes folifer tablets 
100mg of elemental iron and 500μg of folic acid to all pregnant women who 
are not anaemic for at least last 100 days of pregnancy. 
For patients with Hb between 7gm / dl and 11gm/dl – 2 tablets of folifer 
for 103 days. 
Patients with Hb less than 7gm / dl are referred to the first referral 
centres. 
All patients should have their motion screened for ova and cyst.  Those 
with hookworm infestation are given Tab. Albendazole 400mg stat. 
MANAGEMENT DURING LABOUR 
First Stage : 
The  patient should be in bed and should lie in a position comfortable to 
her. 
Arrangements for oxygen inhalation to be kept. 
Strict asepsis to minimise puerperal infection. 
Second Stage 
Asepsis is maintained 
Prophylactic outlet forceps or vacuum delivery to shorten the duration of 
second stage. 
IV methergine 0.25mg at the time of delivery of the head. 
Third Stage  
Be very vigilant 
Significant blood loss to be replaced but post partum overloading of heart 
should be avoided. 
Puerperium 
Prophylactic antibiotics to prevent infection. 
Iron therapy for 3 months after delivery. 
PARAMETERS USED IN THE DIAGNOSIS OF ANAEMIA 
1. Hemoglobin concentration in g/dL  11g/dl (WHO) 
2. Hematocrit or packed cell volume expressed as a percentage  
            35-45% (< 30% anaemia). 
3. Red blood cell count in million per cubic millimetre  
(<4 million/mm3) 
4. Serum iron : normal :  60-150 μg/dL 
5. Percentage saturation of transferrin – (Decreased in anaemia). 
Normally 1:3 saturated. Less than 15% saturation in Iron deficiency 
anaemia. 
6. Total iron binding capacity (Increased in Anaemia) 
Normal : 45-72μmol/L 
7. Serum Ferritin : Decreased in Anaemia 
Normal 15-300 μg/L 
8. Serum folate : Normal : 2-20 μg/L  And 
 Red Cell folate : Normal : > 100μg/L 
 To diagnose folic acid deficiency 
9. Peripheral blood smear to know the type of anaemia and look for  
          malarial parasites. 
INDICES USED IN DIAGNOSIS OF ANAEMIA 
 
¾ MEAN CORPUSCULAR HEMOGLOBIN (MCH) 
 
Hb in g per 1000 ml of blood  
            In Picograms 
 RBC in million per cu. mm 
  
 The normal value is 29.5 mico-micrograms. 
 
 
¾ MEAN CORPUSCULAR VOLUME (MCV) 
 
Volume of packed cells per 1000 ml 
       
 RBC in million per cu. mm 
 
 The normal value is 68 cubic microns 
> 90 => macrocytosis. 
 
¾ MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION  
(MCHC) 
 
Hb in g per 100 ml  
       x  100 
 Volume of packed cells per 100ml 
 
It is normally 34% 
 
It represents the actual hemoglobin concentration in the blood and is the 
key to iron deficiency anaemia. 
  
¾ COLOUR INDEX 
 
Hb (Percentage of normal) 
       
 RBC (Percentage of normal) 
 
It is normally one.  If it is less then one the anaemia is hypochromic.  If 
above one, it is hyperchromic. 
MATERIALS AND METHODS 
1000 antenatal patients attending the AN-OPD at  the Govt. Raja Sir 
Ramaswamy Mudaliar Lying-in Hospital in the year 2004-2005 were selected 
for the study.  These  patients were screened for anaemia as is routinely done. 
INCLUSION CRITERIA 
¾ Patients of all three trimesters, with moderate or severe anaemia 
EXCLUSION CRITERIA 
Patients with low haemoglobin levels whose pregnancy ended in an 
abortion or turned out to be a molar pregnancy  were excluded from the study.  
Patients with PIH were also excluded from the study. 
For all the patients in the study the following parameters were measured  
¾ Haemoglobin concentration in g/dl 
¾ Haematocrit % 
¾ Total RBC count million / mm3 
¾ Total WBC count 
¾ Platelet Count 
¾ Peripheral smear for type of anaemia and to rule out malaria 
¾ MCV (Mean Corpuscular volume) 
¾ MCH (Mean corpuscular haemoglobin) 
¾ MCHC (Mean Corpuscular Haemoglobin Concentration) 
METHODS OF ESTIMATION OF HAEMOGLOBIN 
In Sahli’s method, which is commonly used in laboratory practice, the 
haemoglobin is converted to acid haematin by placing 0.1 N HCI upto mark 10 
in the graduated tube, and adding 20 cu.mm of blood to it.  It is then diluted 
with water till the colour matches with the standard colour.  It is better to take 
the reading in grams of haemoglobin per 100 ml rather than in percent Hb.  If 
the reading is reported as per cent, how much Hb corresponds to 100% in the 
instrument must be indicated, as they may vary from 14 to 16gm in different 
instruments. 
ESTIMATION OF RED CELLS  
The concentration of RBC or WBC may be obtained by counting them 
directly after suitable dilution with special solutions. The instrument used for 
this purpose is called a' haemocytometer.  
The diluting fluid that is usually used for RBC count is Hayem's fluid. It 
contains 0.5 gms. of sodium chloride and 2.5 gms. of sodium sulphate, which 
together give it isotonicity with blood. It also contains 0.25 gm. of mercury 
perchloride which along with the sodium sulphate also prevents clumping of 
the cells. Mercuric perchloride fixes the cells or makes the transparent cells 
translucent.  
The method consists of spreading a film of suitably diluted blood on a 
special glass slide on which are marked squares of known dimensions. The area 
is divided into 16 or 25 large squares. Each large square is again divided into 
16 small squares. Each small square is 1/20 mm at the edge. The area is 
therefore 1/400 sq. mm. The thickness of the film when the cover glass is in 
position is 0.1 mm. The film standing on 1 small square will be 1/4000 cu. mm. 
The stem and the pipette bulb are so arranged that a dilution of 1 : 200 is 
obtained.  . The number of RBC in 80 small squares is counted. If N is the total 
number counted in all the 80 squares, the average number in each square is then 
N/80. The volume of fluid in each small square is 1/4000 cu. mm. The dilution 
is 1/200. Therefore the number of cells in 1 cu. mm of undiluted blood is N x 
10,000. Thus, the value can be derived by adding 4 zeros to the total number 
obtained by counting the cells in 80 small squares.  
For counting WBCs a different diluting   fluid is used, containing acetic 
acid to destroy RBCs and methylene blue to colour the nuclei of WBCs and the 
dilution is 1/20.  There are four large squares (1mm2) at four corners out side 
the RBC counting chamber not shown in the figure. Each is divided into 16 
smaller squares. The number of WBCs in all the four large squares are counted 
and value multiplied by 50 gives the WBCs in 1 cu.mm. 
PERIPHERAL BLOOD SMEAR  
Make a blood smear on a glass slide, stain it with Leishman stain and 
examine it.  With this, one can (i) get an idea of the changes in size, shape, 
colour of RBCs in anaemias. Abundant  presence of small pale staining cells 
with variation in size  (anisocytosis) and shape (poikilocytosis) suggest 
microcytic hypochromic anaemia.  Macrocytosis is observed when cells are 
large in size and volume  and seen in megaloblastic anaemia. Target cells seen 
in haemoglobinopathies are flat cells with haemoglobin arranged as a central 
mass and an outer ring with a pale zone in between. One can also detect the 
presence of malarial parasite if patient has malaria.  
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The patients were  then followed upto delivery and the following 
parameters of perinatal outcome were noted. 
¾ Alive or dead fetus at delivery 
¾ Term or preterm delivery 
¾ Mode of delivery – normal / instrumental / caesarean.  
¾ Birth weight of the baby 
¾ APGAR scoring at 1 minute and 5 minutes 
¾ Any early neonatal complications or death. 
The following parameters of  Maternal Outcome were noted : 
¾ Intercurrent infection 
¾ Compensated or in congestive failure 
¾ Shock 
¾ PPH 
¾ Puerperal sepsis 
¾ Subinvolution 
¾ Thromboembolism 
¾ Maternal Death 
OBSERVATION, RESULTS AND DISCUSSION 
A total of 1000patients attending the antenatal OPD were taken at 
random into the study.   
They were screened for anaemia.  
There were a total of 137 patients who fell into the category of moderate 
and severe anaemia. 
The maternal and fetal outcome in these 137 patients were studied in 
great detail. 
Total number of patients  =  1000 
 
< 7gm /dl  =   25   
7.1 to 9gm/dl  = 112 
9.1 to 10gm/dl = 786 
10.5 to 11 gm/dl =   40 
> 11gm/dl  =   37 
13.7% belonged to moderate and severe anaemia.  Maximum number of 
patients were mildly anaemic, 78.6% having Hb 9.1 to 10gm/dl. 
70% of the population works in factories located in North Chennai and 
belong to the lower economic strata (Group V) 
TABLE – 1 
 
AGE / GRAVIDA 
Patients with Hb < 9gm% 
 
Total 137 
Total 
number 
of cases 
Age 
(Years) 
Primi G2 G3 G4 G5 G6 
24 17-20 12 11 - 1 - - 
68 21-25 26 26 14 2 - - 
35 26-30 5 12 14 3 1 - 
10 >30 1 4 - 1 1 3 
137  44 53 28 7 2 3 
 
Maximum patients clustered in the 21-25 year age group. They were 
mostly primis or second gravida. Beyond 30 years, women were of a higher 
gravida. As age increased the parity also increased.  
17.5% of cases were teenagers. 
They clustered round the primi and second gravida. 
In my study early marriage, early pregnancy, frequent pregnancies with 
short interdelivery intervals were all factors that increased the incidence and 
prevalence of anaemia in the population of North Chennai. 
 
TABLE  - 2 
AGE / GESTATIONAL AGE 
 
 
Trimester Total 
Number of 
Cases 
Age (Years) 
I II III 
24 17-20 0 2 22 
68 21-25 5 3 60 
35 25-30 3 1 31 
10 > 30 0 1 9 
137  8 7 122 
 
It was noticed in my study group that despite whichever age groups the 
anaemic patient belonged to, awareness  was so poor, as most of them came to 
our hospital only in the III trimester or when they had symptoms.  Most of the 
patients were labourers who had to earn a living even during pregnancy.  They 
preferred to work, rather than to come for regular antenatal checkups and get 
admitted for treatment of anaemia unless it was very severe. 
 
 
 
TABLE – 3 
AGE / HAEMOGLOBIN 
Haemoglobin Total Number 
of Cases 
Age (Years) 
<  7 gm/dL 7.1 to 9 
24 17-20 5 19 
68 21-25 13 55 
35 26-30 4 31 
10 >30 3 7 
137  25 112 
  18.248% 81.7518% 
  Severe Anaemia Moderate 
Anaemia 
 
18.24% of patients had severe anaemia and 81.75% had moderate 
anaemia in the group of patients with Hb< 9gm/dl. 
TABLE 4 
HAEMOGLOBIN DISTRIBUTION OF THE 1000 CASES 
Total 
Number of 
Cases 
Hb 
Conc. < 
7gm % 
7.1to9gm% 9.1 to 
10gm% 
10.5 to 
11gm%
Above 11 
gm% 
25 112 786 40 37 
1000 
2.5% 11.2% 78.6% 4% 3.7% 
 
Of the total 1000 patients – maximum patients had Hb between 9.1 to 
10gm / dl (78.6%). 
2.5% had severe anaemia 
11.2% had moderate anaemia 
78.6% had mild anaemia. 
Patients with mild anaemia never even considered themselves to require 
treatment.  Neither did they come for regular antenatal check up, nor were they 
compliant with oral iron therapy. 
TABLE 5 
GRAVIDA / HB 
 
Haemoglobin Total Number 
of Cases 
Gravida 
< 7 gm/dL 7.1 to 9gm/dL 
44 Primi 4 40 
53 G2 12 41 
28 G3 3 25 
7 G4 - 7 
2 G5 1 1 
3 G6 2 1 
 
There were 48 G3 patients in the 1000 population studied. 
Of these 25 were 7.1 to 9gm /dL 
 3 were < 7gm /dL. 
And 18 were 9.1 to 10  gm / dL. 
Only 2 were > 10.5gm / dL. 
Out of the 940 primis and gravida 2 only 97 had severe to moderate 
anaemia.  
All patients who were fourth gravida and above suffered from moderate 
to severe anaemia. 
Increasing parity does increase the incidence and severity of anaemia in 
the  population of North Chennai. 
The adoption of family planning was poor in North Chennai. Few 
patients came 4-6 weeks after delivery for CuT insertion.  The acceptance of 
oral pills was also not very high.  Most patients  came as third or fourth gravida 
in the first or second trimester for MTP!  This category included women with 
previous 2 LSCS who were totally unaware of the risk of MTP and those of 
another pregnancy. Hence we are strengthening our family welfare 
programmes and outreach services to tackle this group of patients. 
TABLE 6 
GESTATIONAL AGE / Hb 
 
Hb GA Trimester < 7gm% 7.1 to 9gm% 
Total 
I 2 6 8 
II 5 2 7 
III 18 104 122 
 25 112 137 
 
Most of the patients with moderate and severe anaemia came for their 
first antenatal check-up only in the  third trimester. 
 
TABLE 7 
HB / PERIPHERAL SMEAR 
 
Peripheral Smear Total Number of 
Cases  with Hb < 
9gm/dL 
Microcytic 
hypochromic 
Normocytic 
hypochromic 
95 42 
137 
69.34% 30.656% 
 
There were  no cases of macrocytic anaemia.  Maximum cases had 
microcytic hypochromic smear and showed drastic improvement with iron 
medication. 
Nutritional deficiency was the major cause of anaemia in North 
Chennai.  All the patients in the study group were unaware of food items rich in 
iron.  As they came in the III trimester, they neither had iron medication, nor a 
chance to correct their dietary habits. 
 
TABLE 8 
BIRTH WEIGHT  VS HAEMOGLOBIN 
 
Birth weight > 3Kg < 7gm/dL 7.1 to 9gm /dL 
> 3 kg 5 25 
2.5 to 2.99 kg 5 45 
2 to 2.499 kg 10 23 
1.5 to 1.99 kg 3 15 
1 to 1.499 kg 1 3 
 
Low Birth Weight – A newborn whose weight is less than 2500 grams. 
Very low birth weight -  A newborn whose weight is less than 1500 
grams 
Extremely – Low birth weight – A new born whose weight is less than 
1000 grams 
Percentage Distribution of LBW in patients with Hb <  9gm /dL 
(Moderate to severe anaemia) 
In patients with moderate to severe anaemia 40.74% of babies were 
LBW. 
Of the 40.74% LBW babies 7.27% were very low birth weight babies. 
Patients who had initially Hb< 7gm% and came in I or II trimester 
(0.7% of the 1000 patients) had better outcomes.  There was No incidence of 
LBW in these cases.  Unbooked patients with severe anaemia in III trimester 
had more incidence of LBW. 
This clearly shows the importance of regular antenatal checkups in 
improving the fetal outcome. Unfortunately in North Chennai it was a very 
small group (0.7%) who came early and enjoyed the privilege  of a better fetal 
outcome. 
 
TABLE 9 
PATIENTS WITH Hb < 9gm /dL   Gravida Vs Birth weight 
 
Birth Weight Gravida 
< 2.5 Kg. 2.5 kg and above 
Primi 17 (38.63%) 27 
Gravida 2 22 (42.30%) 30 
Gravida 3 11 (40.74%) 16 
Gravida 4 3 (50%) 3 
Gravida 5 0 2 
Gravida 6 1 2 
 
As the gravida increases the percentage of LBW also increases. 
The Gravida 5 and Gravida 6 patients were those where anaemia was 
detected and treated in II trimester. 
 
TABLE 10 
 
Gravida Vs Birth Weight  in patients treated in I and II trimester and 
those who came in III Trimester 
 
Treated early Treated in III Trimester Weight  
Gravida in 
Kg. 
< 2.5 2.5 & above < 2.5 2.5 and 
above 
Primi 2 4 15 23 
G2 2 2 20 28 
G3 2 2 20 28 
G3 0 3 11 13 
G4 0 0 3 3 
G5 0 1 0 1 
G6 1 0 0 2 
 
 
Treated early Treated in III trimester 
Gravida <2.5 kg 2.5 and above <2.5Kg 
2.5 and 
above 
Primi  2 (33.33%) 4 15 (39.47%) 23 
Gravida 2  2 (50%) 2 20 (41.66%) 28 
Gravida 3 0 (0%) 3 11 (45.83) 13 
Gravida 4 0 (0%) 0 3 (50%) 3 
 
Among primis the percentage of LBW was higher among the group 
which came in the III trimester. 
All gravida  3 patients who were treated early had babies with birth 
weight above 2.5 kg. 
Early treatment of anaemia does decrease the incidence of LBW. 
 
 
 
 
TABLE 11 
THE IMPACT OF INTER DELIVERY INTERVAL ON 
BIRTHWEIGHT 
 
Inter delivery 
interval 
Birth weight < 
2.5 kg 
2.5 kg and above Total 
< 2 years 15 (55.55%) 12 (44.44%) 27 
> 2 yrs 19 (36.538%) 33 (63.46%) 52 
 
The percentage of LBW was definitely higher in women with inter 
delivery interval less than 2 years. 
As age increased the parity also increased.  Repeated pregnancies at 
short intervals along with  a prolonged period of lactation in the population  of  
North Chennai, put a serious strain on the iron-reserve.  A normal healthy 
woman with adequate diet takes 2 years to replenish about 1000mg of iron lost 
during child birth and lactation. 
TABLE 12 
AGE VS BIRTH WEIGHT 
 
Age < 2.5 Kg 2.5 Kg and above 
17-20 years 11 (47.82%) 12 (52.17%) 
21-25 27 (46.278%) 40 (59.70%) 
26-30 11 (32.35%) 23 (67.64%) 
> 30 years 6 (60%) 4 (40%) 
 
Maximum percentage of low birth weight fell into the > 30 years age 
group. The next were the teenage group. 
Both teenagers and elderly women with anaemia were more prone for 
LBW. Teenagers have an added demand of 270mg iron  for their natural 
growth. This extra requirement comes down to nil by the age of 21 years.  
Hence teenage pregnancies are more prone for anaemia. 
 
TABLE 13 
PRETERM Vs Hb 
 
 < 7gm% 7.1gm to 9gm% 
Number of Cases 3 19 
 
A neonate born before 37 completed weeks (before 259th day) 
 
TABLE 14 
TERM / PRETERM  Vs Hb 
 
Number of Cases <7 gm/dL 7.1gm to 9gm / dL 
Preterm  3 (12%) 19 (16.96%) 
Term 22 (88%) 93 (83.04%) 
 
16.96%  of moderately anaemic patients and 12% of severely anaemic 
patients went for preterm labour. 
Preterm babies had a  higher risk of perinatal morbidity and mortality. 
 
TABLE 15 
MATURITY VS HAEMOGLOBIN 
 
Number of Cases <9 gm/dL 9.1 to10gm/dl 
Preterm 22 (16.05%) 29 (3.68%) 
 
Patients with lower haemoglobin had higher incidence of preterm 
labour. 
TABLE 16 
AGE DISTRIBUTION OF ANAEMIC WOMEN WHO HAD PRETERM 
LABOUR 
 
Age No. of Cases Percentage 
15-20 4 18.18% 
21-25 10 45.45% 
26-30 6 27.27 % 
> 30 2 9.09% 
Of the 22 patients who had preterm labour. 
3 were cases of preterm intrauterine deaths. 
2 cases of early neonatal deaths. 
1 was a case of multiple pregnancy. 
 
 
TABLE  17 
MODE OF DELIVERY IN ANAEMIC WOMEN WHO WENT FOR 
PRETERM LABOUR 
 
Mode of Delivery No. of Patients Percentage 
Vaginal 17 77.27% 
Assisted Breech 1 4.54% 
Outlet forceps 1 4.5% 
LSCS 3 13.63% 
 
APH 
Of the 22 cases, there was 
1 case of abruptioplancentae 
1 case of placenta praevia type II B 
HIV  
There was 1 case with Hb 8.6gm% HIV +ve 
The birth wt. was 1.8kg 
It was a preterm baby 
 
TABLE 18 
BIRTHWEIGHT VS MATURITY 
 
No. of  Cases Birth Weight 
 < 2.5 kg 2.5 kg or above 
Preterm 17 2 
Percentage 89.47% 10.52% 
 
89.47% of preterm babies were low birth weight. Lower the Hb more 
the likelihood of preterm labour.  Prematurity increased the incidence of  low 
birth weight, intrauterine death and early neonatal loss, thereby worsening the 
fetal outcome. 
 
 
TABLE 19 
MATERNAL OUTCOME 
 
Hb Vs Maternal Cardiac Status 
 
 Compensated In failure Total 
Patients With Hb < 
7gm /dl 
20 (80%) 5 (20%) 25 
Patients with 
Hb>7gm /dL 
112 (100%) 0 112 
   137 
 
Patients with moderate anaemia  were not in failure. 
Lower the Hb level the more likelihood of the patient being in failure.  
The 5 patients in this study who were in failure had Hb<5.6gm/dl.  These 
patients were admitted immediately.  The congestive cardiac failure was treated 
as  mentioned earlier and patient kept hospitalised till delivery. Meanwhile the 
Hb status was improved by carefully transfusing packed cells (taking care to 
avoid volume over load) and giving the patients hematinics.  Failure was 
uncommon when Hb was above 7gm/dl. 
 
APH 
Of the 137 patients with moderate and severe anaemia – 
1 case of abruptio placentae 
3cases of placenta praevia were observed.                                                
ATONIC PPH 
TABLE 20 
ATONIC PPH Vs Hb 
 
Hb Level  
< 7gm/dl 7.1-9g/dl > 9g/dl 
Total No. of Cases with 
Atonic PPH 
1 (4%) 3 (2.6%) 2 (0.25%) 
Total No. of Cases in each 
group 
25 112 786 
 
The lower the haemoglobin the greater the risk of atonic PPH. 
 
One patient with atonic PPH had gone for acute inversion of the uterus.  The 
same was repositioned and oxytocics were given to obtain hemostasis.  A unit 
of packed cells was given to improve her general condition.  
 
INFECTIONS 
In the study group there was 
1 case of diarrhoea 
1 case of PUO 
2 cases of LRI 
1 case of UTI 
1 case of skin lesions with dental carries 
1 case of wound gaping in the puerperium. 
MATERNAL MORTALITY 
There was 1 maternal mortality in the study group. 
That is 0.72% higher risk if Hb is less than 9gm/dl 
0% if Hb > 9gm /dl 
PERINATAL MORTALITY 
2 (8%)  deaths in patients with  Hb < 7gm /dl 
3 (2.67%) deaths in patients with Hb 7.1 – 9gm / dl 
A significant rise in Perinatal mortality with decreasing Hb. 
STEPS TO REDUCE MATERNAL MORTALITY  (ACTIONS FOR 
SAFE MOTHERHOOD). 
A) Health Sector Actions. 
¾ Basic antenatal, intranatal and post natal care.  Risk assessment is a 
continued procedure throughout and is not only once.   
¾ A skilled attendant should be present at every birth. 
¾ Emergency obstetric care by field staff at the door step or preferably at the 
FRU. 
¾ Good quality obstetric services at the referral centres. 
¾ Prevention of unwanted pregnancy and unsafe abortion.  All couples should 
have access to effective, client oriented and confidential family planning 
services. 
¾ Frequent joint consultation amongst specialists in the management of 
anaemia in pregnancy. 
¾ Maternal mortality conferences to evaluate the cause  of death and the 
avoidable factors. 
¾ Periodic refresher courses for continuing education of obstetricians, general 
practitioners, midwives and ancillary staff and to high light the preventable 
factors. 
B) Community, Society and Family Actions 
¾ These are essential to safe motherhood. 
¾ Wide range of  groups (Women’s group), health care professionals, 
religious leaders and safe motherhood committees (regional, district) can 
help the women to obtain the essential obstetric care. 
C) Health planners / Policy maker’s action 
¾ To organise community education, motivation and formation of safe 
motherhood committee at the local level. 
¾ To strengthen the referral system for obstetric complications.   
¾ To develop written management protocols for complications like congestive 
cardiac failure, atonic PPH, preterm labour. 
¾ To improve standard and quality of care by organising refresher courses for 
health care personnel. 
¾ Periodic audit of existing health care delivery system and to implement 
changes as needed. 
D) Legislative and Policy Actions 
¾ Girl children and adolescents should have good nutrition, education and 
economic opportunities.  
¾ Barrier to the access of health care facilities should be removed.  
¾ Policies should increase women’s decision making power as regard to their 
own health and reproduction. 
¾ Decentralisation of services to make them available to all the women. 
¾ Post abortion care and treatment of anaemia in these women. 
¾ Social inequalities and  discrimination on grounds of gender, age and  
marital status are to be removed. 
MEASURES HELPFUL IN REDUCING PERINATAL MORTALITY 
¾ Pre-pregnancy health care and counselling  
¾ To correct anaemia at this stage. 
¾ To advice on birth spacing. 
¾ Regular antenatal care with advice regarding health, diet and rest.  
¾ Detection and correction of anaemia and prevention of pre-eclampsia. 
¾ Screening of high risk patients, those of poor socioeconomic status, high 
parity, extremes of age, twins and their mandatory hospital delivery. Risk 
approach to RCH care is essential. 
¾ Careful monitoring in labour. 
¾ Skilled birth attendant – Minimise sepsis – clean hands, clean delivery 
surface and cut the cord clean.   
¾ Provision of referral neonatal service to look after low birth weight and 
preterm babies. 
¾ Health care education of the mother about the care of the new born- early 
and exclusive breast feeding. 
¾ Educating the community to utilise family planning services and utilise the 
available MCH services. Family planning services can prevent unwanted 
pregnancies. 
¾ Autopsy studies of all perinatal deaths. 
¾ Continued study of perinatal mortality problems by demographic studies, 
regular clinically allied inter-departmental  meeting and pathological 
research. 
 
SUMMARY 
 In this study of 1000 patients there were 2.5% severe, 11.2% moderate and 
78.6% mildly anaemic patients. 
 Most of the patients with moderate and severe anaemia came for the first 
time to our hospital only in the III trimester. 
 Maximum number of patients fell in the mild anaemia group and of them 
most of patients had Hb between 9.1 and 10 gm /dl 
 As the parity increases the Hb concentration decreases. 
 17.5% of cases were teenagers.  Early marriage, frequent pregnancies at 
short intervals increased the incidence and severity of anaemia in the 
population. 
 Most of the anaemic patients had microcytic hypochromic anaemia. 
 The percentage of babies with birth weight less than 2.5kg was 40.74% 
among the moderate and severely anaemic patients. 
 28% of severely anaemic patients came for  regular antenatal checkups and 
had no incidence of low birth weight. 
 In unbooked anaemic patients as gravidity increased the percentage of low 
birth weight also increased. 
 When the inter delivery interval was less than 2 years the incidence of low 
birth weight increased. 
 There was poor acceptance of family planning measures especially when 
patients had children of same sex or when they wanted a male child. 
 Anaemic women who belonged to the teenage group or > 30 year group had 
higher incidence of low birth weight. 
 As Hb concentration decreases the incidence of prematurity increases. 
Prematurity  increased the incidence of low birth weight, intrauterine death 
and early neonatal loss. 
 Lower the Hb, more was the chance of congestive cardiac failure. The 
patients in this study had Hb < 5.8gm/dl. 
 Lower the Hb the more was the risk of atonic PPH and infections. 
 There was 1 Maternal mortality in the group with Hb < 9gm /dl and  none in 
the group of mild anaemia. 
 The perinatal mortality was 8% in severely anaemic patients and 2.67% in 
moderately anaemic patients,  nearly a fourfold increase. 
CONCLUSION 
 
¾ The incidence of mild anaemia in North Chennai is very high.  In most of 
them the pregnancy is uneventful.  Nutritional anaemia and hookworm 
infestation were the most likely cause, as all patients who came early 
showed drastic improvement in maternal and fetal outcome with treatment 
of the same. 
¾ Lower the haemoglobin, greater was the incidence of low birth weight, 
preterm labour and perinatal mortality. Early treatment did decrease the 
incidence of the above complications.  But most of the patients paid their 
first visit only in the late third trimester. Women who had preterm labours 
had higher incidence of perinatal mortality. 
¾ The study clearly showed that maternal morbidity like congestive cardiac 
failure, atonic PPH and infections and maternal mortality was higher when 
haemoglobin concentration fell. 
¾ The people of North Chennai had no knowledge of the food items rich in 
iron and folic acid.  The acceptance of family planning measures was poor.  
Repeated pregnancies with shortened inter-delivery intervals increased the 
severity of anaemia in this population.  Poor hygiene, cooking taboos and 
fallacies played a major role in worsening the picture. 
¾ This study emphasises the need for increased awareness, regular antenatal 
checkups, early detection and treatment of anaemia in the population of 
North Chennai.  It also emphasises the need to strengthen our out reach 
services and family welfare services. 
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PROFORMA 
 
Name :   Age  :  I.P.No. Serial No. : 
Husband’s Name    Occupation and Income : 
Address :     Religion : 
Date of Admission :    Height : 
Date of Discharge :    Weight : 
Present History : 
 H/o. Breathlessness 
 H/o Worm infestation 
 H/o. Chronic blood loss 
 H/o. Haemarrhoids 
 H/o. Malaria 
MENSTRUAL HISTORY 
 H/o. Frequency of cycles, duration of flow 
 H/o. Passing blood clots 
 Last menstrual period 
OBSTETRIC HISTORY 
Gravida  Para   Live  Abortion 
Birth Spacing 
LMP  (Trimester) 
EDD   
Past Medical and Surgical History 
Diet History 
Physical Examination 
¾ Stature 
¾ Build 
¾ Presence of Pallor 
¾ Examination of Cardiovascular system 
¾ Examination of Respiratory System 
¾ Abdomen 
INVESTIGATIONS 
Hb gm/dl 
Hematocrit 
TRBC count 
MCV  MCH 
MCHC 
TWBC 
DC 
Platelet Count 
Peripheral Blood Smear 
T protein 
Se Albumin 
Motion ova 
Cyst 
ULTRASOUND 
ASSOCIATED FACTORS 
¾ PIH 
¾ Abruption 
¾ Infections 
MOTHER 
¾ Compensated / Failure 
¾ Shock 
¾ PPH 
¾ Peripheral vein thrombosis 
¾ Maternal Death 
DELIVERY DETAILS 
Term / Preterm 
Vaginal / Caesarean 
BABY 
Alive / IUD 
Term / Preterm 
Birth weight 
Apgar Scoring at 1 minute and 5 minutes 
NEONATAL PERIOD 
¾ Alterations of sensorium 
¾ Sepsis 
¾ Convulsions 
¾ Jaundice 
¾ Birth injury 
¾ Neonatal death 
TREATMENT RECEIVED 
¾ Oral iron and folate tablets 
¾ IV Iron – Imferon 
¾ Packed cell transfusion 
¾ Treatment of failure. 
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Alive / 
IUD
Term / 
Preterm
Birth 
Weight
Apgar 
Score/10 
for 1' & 5'
1 11265 26 2 III 8.6 10 - - - LSCS Alive Term 2.6 6, 9 -
2 12369 24 Primi III 8.8 - - - - L-Naturale Alive Term 2.9 8, 9 -
3 11612 21 2 III 8 1 Post molar preg. - - L-Naturale Alive Term 2.6 6, 10 -
4 11729 35 6 III 7 6 - - - L-Naturale Alive Term 2.4 6, 8 -
5 11585 45 Primi III 8.6 - Breach - - LSCS Alive Term 2.4 8, 10 -
6 11575 20 Primi III 8.2 - - - - LSCS Alive Term 2.5 6, 8 -
7 11110 27 5 II 6 3 - - - L-Naturale Alive Term 3.25 7, 8 -
8 11821 30 3 III 8.2 4 - - - L-Naturale Alive Term 2.9 7, 8 -
9 11894 18 Primi III 8.6 - - - - L-Naturale Alive Term 2.9 8, 9 -
10 11527 20 3 III 8.8 3 Prev. LSCS - - LSCS Alive Term 2.4 7,8 -
11 11370 23 2 III 8.8 2 Prev. LSCS - - LSCS Alive Term 2.5 6, 8 -
12 12225 23 Primi I 4 - - - - L-Naturale Alive Term 2.6 6, 8 -
13 12226 35 2 III 8.6 6 - - - L-Naturale Alive Term 2.9 5, 6 -
14 10435 35 2 III 7.6 1 Multiple pregnancy - - L-Naturale Alive Preterm 1.7, 1.75 6,8 -
15 9523 26 Primi I 7.4 - HbsAg +ve, Rh -ve - - LSCS Alive Term 2,5 4,7 -
16 11554 35 2 III 8.6 3
Central 
Placenta 
Praevia
- - LSCS Alive Term 2.75 6, 9 -
17 11479 22 Primi III 8.6 - - - - Outlet forceps Alive Term 3.25 6, 8 -
18 11573 35 6 III 8 2 - - - L-Naturale Alive Term 3.5 6, 8 -
19 11478 24 Primi III 8.4 - - - - L-Naturale Alive Term 2.3 6, 8 -
Hb
Birth 
spacing 
(Years)
Associated
factors
Maternal 
Morbidity
Maternal 
mortality
Mode of 
Delivery
Neontal 
Deaths
MASTER CHART
Fetal 
Sl. 
No. IP No. Age Gravida
First 
Vist at 
20 11456 20 2 III 8.6 1 3/4 Multiple pregnancy - - L-Naturale Alive Term 2.5, 2 6,8 -
21 11448 23 Primi III 8 - - - - L-Naturale Alive Preterm 2.25 8, 10 -
22 11427 25 2 III 6.8 6  - - L-Naturale Alive Term 3 8,9 -
23 11137 19 2 III 8.2 1 - - - LSCS Alive Term 1.8 3, 8 -
24 11297 20 2 II 8.6 1½ - Diarrhoea - L-Naturale Alive Term 2.4 6,8 -
25 11277 28 2 III 6.2 4  - - L-Naturale Alive Term 2 6, 8 -
26 11026 20 Primi III 8 - Breech - - Assisted Breech Alive Preterm 1.95 2, 6 -
27 10622 21 Primi III 4.8 - - Congestive failure - L-Naturale Alive Preterm 1.5 6, 8 +
28 10865 20 2 III 6.8 2 Placenta Previa IIB - - LSCS Alive Preterm 2.65 7, 9 -
29 11120 23 2 III 8.8 4 - - - L-Naturale Alive Term 2.75 5, 7 -
30 11231 18 Primi III 8 - - - - L-Naturale IUD Preterm 1.25 - -
31 11218 23 3 III 8.8 3 Prev. LSCS - - LSCS Alive Term 3.1 5, 8 -
32 10688 30 Primi III 8 -  - - LSCS Alive Preterm 1.7 5, 8 -
33 11155 30 Primi III 8.6 - Breech - - LSCS Alive Term 3.25 6, 8 -
34 11226 22 2 III 8.8 1½ - - - L-Naturale Alive Term 3.25 6, 8 -
35 11242 37 2 III 7.6 1 - - - L-Naturale Alive Term 2.3 5, 8 -
36 11547 18 2 III 8.6 1½  - - L-Naturale Alive Term 2.3 6, 8 -
37 12156 21 Primi III 8.6 - HIV +ve - - L-Naturale Alive Preterm 1.8 6, 7 -
38 12136 25 3 III 6.8 - - - - L-Naturale Alive Term 3 6, 8 -
39 11904 20 Primi III 6.2 - - - - L-Naturale Alive Term 2.1 6, 8 -
40 11876 19 Primi III 8 - - Atonic PPH - L-Naturale Alive Term 2.75 6, 8 -
41 12158 23 Primi I - - - - - L-Naturale Alive Term 2.25 4, 6 -
42 12241 21 Primi III 8.3 - - - - L-Naturale Alive Term 3.25 8, 9 -
43 12335 20 Primi III 8.6 - - - - L-Naturale Alive Preterm 1.8 4, 8 -
44 12336 22 Primi III 8.4 - - - - L-Naturale Alive Term 3.3 5, 8 -
45 11961 23 Primi III 7.6 - - Wound gaping - LSCS Alive Term 2.5 5, 8 -
46 12549 20 2 III 5.5 1½ Placenta Previa IIB - - LSCS Alive Term 2.5 8, 9 -
47 12137 29 2 III 8.8 1 Prev. LSCS - - LSCS Alive Term 3.7 5, 8 -
48 12152 25 Primi III 8 - HbsAg +ve - - LSCS Alive Term 3.35 8, 9 -
49 12710 23 Primi III 8 - - -- - L-Naturale Alive Term 2.5 6, 8 -
50 12596 26 Primi III 8.8 - - - - L-Naturale Alive Term 2.5 8, 9 -
51 11897 23 Primi III 8.8 - - UTI - L-Naturale Alive Preterm 1.45 6,7 -
52 11842 24 2 III 6 1½
Prev. 
LSCS, 
Heart 
Disease
- - L-Naturale Alive Term 2.25 5, 8 -
53 12402 25 2 III 7.2 2 - - - L-Naturale Alive Preterm 2.5 6, 8 -
54 12325 28 3 III 8.4 4 - - - L-Naturale Alive Term 3.5 8, 10 -
55 12324 27 3 III 8.4 4 - - - L-Naturale Alive Term 3.25 9, 10 -
56 11781 19 Primi II 5.6 - - - - L-Naturale Alive Term 2.3 6, 8 -
57 10887 29 3 III 5.6 3   multiple pregnancy - - L-Naturale Alive Term 1.9, 2 7, 8 -
58 11834 28 2 III 7.4 2 3/4   multiple pregnancy - - L-Naturale Alive Term 1.8, 1.9 7, 9 -
59 11835 18 Primi III 8.8 - - - - L-Naturale Alive Term 2.75 6,8 -
60 11551 28 4 III 7.6 2 - - - L-Naturale Alive Term 2.7 6, 8 -
61 11366 26 4 III 8.8 1 - Gr.I Abruption - L-Naturale Alive Preterm 1 4, 6 -
62 11465 32 6 III 6 1 - Congestive failure - L-Naturale Alive Term 2.4 6, 8 -
63 11097 21 2 III 7 2 - - - L-Naturale Alive Term 2.9 7,8 -
64 12400 22 2 III 8.6 1 - - - L-Naturale Alive Preterm 1.55 6, 8 -
65 12541 19 Primi III 8 - - - - LSCS Alive Term 2.6 8, 9 -
66 12958 21 Primi III 8.6 - - - - L-Naturale Alive Term 2.4 8, 9 -
67 12949 21 Primi III 8.6 - - - - L-Naturale Alive Term 3.5 6, 8 -
68 11543 25 3 III 5 3 - - - L-Naturale Alive Term 2.9 7, 9 -
69 11535 26 2 III 8.4 4 - - - L-Naturale Alive Term 2.5 8, 10 -
70 11848 22 3 III 8.6 1½ - - - LSCS Alive Term 2.8 6, 8 -
71 8343 23 Primi III 8.6 - - - - Outlet forceps Alive Term 2.9 5, 6 -
72 11930 30 3 III 8 1 - - - L-Naturale Alive Term 1.75 7, 9 -
73 12035 22 3 I 8.8 1 - - - L-Naturale Alive Term 2.6 6,8 -
74 12159 35 5 III 8 1 - - - L-Naturale Alive Term 2.5 6, 8 -
75 12104 27 3 III 7.8 1½ - - - L-Naturale Alive Term 3.25 6, 8 -
76 12237 25 3 III 8 1½ - - - L-Naturale Alive Term 2.2 8, 10
77 13048 25 3 III 7.6 2 - - - L-Naturale IUD Preterm 1 - -
78 11969 24 Primi III 8.6 - Rh -ve - - L-Naturale Alive Term 2.6 6, 8 -
79 12193 18 Primi III 8 - - - - L-Naturale Alive Term 2.7 4, 8 -
80 11847 23 Primi I 8.8 - - - - L-Naturale Alive Term 2.6 6, 8 -
81 11555 25 Primi III 6 - - Atonic PPH - L-Naturale Alive Term 2.3 8, 9 -
82 11508 33 3 III 8.8 11 - - - L-Naturale Alive Preterm 2.1 5,9 -
83 11873 21 2 III 8 1 - - - L-Naturale Alive Term 1.5 3, 5 -
84 11877 24 4 III 8.4 2½ PUO - - L-Naturale Alive Preterm 2.1 6, 9 -
85 11960 22 2 III 8.8 1 - - - Outlet forceps Alive Term 2.6 6, 8 -
86 11844 22 2 III 8.8 3 - - - L-Naturale Alive Term 1.9 6,8 -
87 11901 30 2 III 8 1½ Schizophrenia - - L-Naturale Alive Term 2.75 6,8 -
88 12331 28 2 III 8.6 4 - - - L-Naturale Alive Term 3 8,9 -
89 12477 28 3 III 8 1 Breech - - Assisted Breech Alive Term 2.4 4, 6 -
90 12633 26 3 I 8.2 4 - - - L-Naturale Alive Term 2.6 6, 8 -
91 12699 20 2 III 8.2 1  - - L-Naturale Alive Term 2.8 6, 8 -
92 12729 30 2 III 8 5 - - - L-Naturale Alive Term 2 6, 8 -
93 12784 19 2 III 8.8 1 - - - L-Naturale Alive Term 2.8 8, 9 -
94 12228 27 3 III 8 3 - - - L-Naturale IUD Preterm 1 - -
95 13092 21 4 III 8.6 1 - Atonic PPH - L-Naturale Alive Term 2.3 6, 8 -
96 12821 26 3 III 7.6 2 - - - L-Naturale Alive Preterm 1.6 6,8 -
97 12973 22 2 I 4.8 2 - Congestive failure - L-Naturale Alive Term 2.3 6, 8 -
98 12837 25 Primi III 8 - Rh -ve - - L-Naturale Alive Term 2.75 6, 8 -
99 12790 30 2 III 8.8 1½ - - - L-Naturale Alive Term 2.2 6, 8 -
100 12789 23 3 III 8 4 - - - L-Naturale Alive Preterm 1.75 4, 8 -
101 12517 25 3 III 8.8 2 Prev. 2 LSCS - - LSCS Alive Term 3.5 8, 9 -
102 12500 25 2 III 7 2 - - - L-Naturale Alive Term 2.25 6,7 -
103 10478 27 3 III 8 1½ - - - L-Naturale Alive Preterm 1.2 4,6 +
104 10933 23 2 III 7.6 2  - - L-Naturale Alive Term 1.25 4, 5 +
105 10977 21 3 III 8.6 1 3/4 - - - L-Naturale Alive Term 2,25 6, 8 +
106 10724 23 2 III 8.8 2 - - - LSCS Alive Term 3.1 7, 8 -
107 10805 25 3 III 8.8 3 - - - L-Naturale Alive Term 2.7 5, 8 -
108 10631 22 2 III 8.8 4 - - - L-Naturale Alive Term 2.75 5, 8 -
109 11095 23 2 III 8.8 3 - - - L-Naturale Alive Term 2.4 8, 9 -
110 10737 28 2 III 8.8 2 - - - L-Naturale Alive Term 2.75 5, 8 -
111 10744 25 Primi III 8.2 - - - - L-Naturale Alive Term 3 6,8 -
112 10585 30 4 III 8.6 3  - - L-Naturale Alive Term 2.9 5, 8 -
113 10609 30 2 III 8 3 - LRI - L-Naturale Alive Term 3.3 6, 8 -
114 10755 21 2 III 7 1½ - - - L-Naturale Alive Term 2.5 6, 8 -
115 10756 28 3 III 8.6 2 Prev. LSCS - - VBAC Alive Term 3.2 6, 8 -
116 10766 20 Primi III 8.8 -  - - L-Naturale Alive Term 2 6,8 -
117 10779 24 2 III 8 - - - - L-Naturale Alive Term 2.5 8, 10 -
118 9582 22 2 III 8 5 - LRI - LSCS Alive Term 1.9 6, 8 -
119 9763 20 2 III 5.8 1 - - - L-Naturale Alive Term 1.9 6, 8 -
120 9664 25 4 III 8.8 1½ - - - L-Naturale Alive Term 2.5 6, 8 -
121 9691 30 3 III 8.4 1 - - - L-Naturale Alive Term 2.75 6, 8 -
122 9940 18 2 III 7.8 1½ - - - L-Naturale Alive Term 2.6 6,8 -
123 9553 23 Primi III 8.8 - - - - LSCS Alive Term 3.1 6,8 -
124 10681 23 2 III 8.6 - - - - L-Naturale Alive Term 3.75 6, 8 -
125 9367 20 2 III 8.8 1 - - - LSCS Alive Term 2.8 3, 4 +
126 10210 29 2 I 8.8 1 - - - L-Naturale Alive Term 3 6, 8 -
127 9962 24 2 III 8.6 2½ - - - L-Naturale Alive Term 2.3 6, 9 -
128 9992 24 Primi II 8.8 - - - - L-Naturale Alive Term 2.5 6, 7 -
129 7564 24 2 III 6.6 2 - - - Outlet forceps Alive Preterm 2 6, 7 -
130 10228 22 Primi III 8.8 - - - - L-Naturale Alive Term 3.25 7, 8 -
131 9937 23 2 III 8.6 2 - Atonic PPH - L-Naturale Alive Term 2.5 6,8 -
132 9983 22 2 III 8 1½ - - - L-Naturale Alive Preterm 1.8 6,8 -
133 9741 23 3 III 8.8 5 - - - L-Naturale Alive Term 2.1 6, 8 -
134 10168 22 Primi III 8 - -
Dental 
Carries
Skin 
Lesions
+ L-Naturale Alive Term 2 8, 10 -
135 12865 28 3 III 7 5 - - - L-Naturale Alive Term 3.3 7, 9 -
136 13054 24 Primi 8.2 - - - - - L-Naturale Alive Term 3.25 8, 10 -
137 13078 25 3 8.8 3 - - - - L-Naturale Alive Term 3 6, 8 -
